Top news of the week: 07.09.2023.
Nimbus Therapeutics raises $210 million in one of the larger fund-raising rounds this year
The Boston-based biotech will work on new "small molecule" drugs to combat cancer and other ailments.
A biotech company says it put dopamine-making cells into people’s brains
The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.
Arcus Biosciences (RCUS): A Modestly Undervalued Gem?
An In-Depth Analysis of Its Market Value
You Are Likely To Live Longer Than You Think: Day Four Of The 10th ARDD Meeting Featuring Minister Mette Kierkgaard
Day four out of five of the 10th ARDD was full of new revelations. For example we learned that that median lifespan of taurine-treated mice increased by 10 to 12%!
Probing the substrate binding modes and catalytic mechanisms of BLEG-1, a promiscuous B3 metallo-β-lactamase with glyoxalase II properties
BLEG-1 from Bacillus lehensis G1 is an evolutionary divergent B3 metallo-β-lactamase (MBL) that exhibited both β-lactamase and glyoxalase II (GLXII) activities. Sequence, phylogeny, ...
New AI-Enhanced Bandages Poised to Transform Wound Treatment
Doctors, engineers, and AI experts are teaming up to develop “smart bandages” capable of treating chronic wounds, battlefield injuries, or even minor cuts and scrapes.
Exploring the antimicrobial peptidome of nematodes through phylum-spanning in silico analyses highlights novel opportunities for pathogen control
Author summary Nematodes include some of the most abundant animals on Earth, found in almost every natural habitat. Globally, parasitic nematodes cause major impacts to human, animal and ...
Here's Why We're Not At All Concerned With Olink Holding's (NASDAQ:OLK) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...